Back to search

Belgium· BE-AMP-SAM463733-00

Refluxineg Antacid 500 mg - 267 mg

A alginic acid product containing sodium alginate, registered in Belgium by EG. The same ATC class is registered in 10 of our 19 countries.

ATC A02BX13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRefluxineg Antacid 500 mg - 267 mgATCA02BX13REGISTER NO.BE-AMP-SAM463733-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Alginic acid is registered in 10 of 19 countries.

Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Alginic acid · ATC A02BX13

10 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sodium Alginate
Manufacturer
EG
Country
Belgium (BE)
ATC code
A02BX13
ATC class
Alginic acid
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3396801

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alginic acid in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alginic acid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Bulgaria · Хепароид
  • Czechia · Heparoid
  • Slovakia · Heparoid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fac59102-17d7-4560-a156-d8b64a344044
GET /v1/drugs/fac59102-17d7-4560-a156-d8b64a344044?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral suspension",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Refluxineg Antacid 500 mg - 267 mg",
  "name_fr": "Refluxineg Antacid 500 mg - 267 mg",
  "name_nl": "Refluxineg Antacid 500 mg - 267 mg",
  "amp_code": "SAM463733-00",
  "strengths": [
    "50.0000",
    "50.0000",
    "26.7000",
    "26.7000"
  ],
  "pack_count": 2,
  "substances": [
    "Sodium Alginate",
    "Sodium Hydrogen Carbonate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Alginic Acid",
  "authorisation_numbers": [
    "BE463733"
  ]
}

See everything about alginic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.